← All stocks

Innoviva, Inc.

INVA Net selling
CIK 0001080014 #2241 in the set updated 18 Sep 2026
Bought (120 mo)
$8.77M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$422.45M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$422.45M
28 of 28 sales
Net
−$413.68M
−$413.68M against sales at will

By person

27 insiders · 43 transactions
8.3×

Pavel Raifeld holds 8.3 times base salary in stock. $4.99M of shares against $600.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Pavel Raifeld last reported holding, valued at $17.52, the price Common Stock, par value $0.01 per share was last bought or sold at on the open market here, on 6 Mar 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GSK plc entity
10% owner
$392.06M (1)
−$392.06M
0
0.0000%
$0.00
−100.0%
DENNER ALEXANDER J
10% owner
$7.98M (9)
$28.40M (3)
−$20.42M
5,658,705
7.83%
$99.13M
−14.9%
Bickerstaff George
Director
$651.75K (4)
+$651.75K
137,207
0.1899%
$2.40M
Witek Theodore J. Jr.
Sr. VP & Chief Scientific Off.
$591.00K (5)
−$591.00K
247,767
0.3430%
$4.34M
+54.7%
dEsparbes Eric
SVP and CFO
$460.94K (8)
−$460.94K
373,081
0.5164%
$6.54M
+54.4%
ABERCROMBIE GEORGE B
Sr. VP & Chief Comm. Officer
$429.29K (4)
−$429.29K
285,479
0.3952%
$5.00M
+63.6%
Zhen Marianne
Chief Accounting Officer
$350.17K (6)
−$350.17K
56,389
0.0781%
$987.81K
+49.9%
Aguiar Michael W
President & Chief Exec Officer
$157.79K (1)
−$157.79K
980,907
1.36%
$17.18M
+41.5%
HULME GEOFFREY
Interim Principal Exec Officer
$103.60K (1)
+$103.60K
49,751
0.0689%
$871.52K
+177.0%
Raifeld Pavel
Chief Executive Officer
$32.60K (1)
+$32.60K
284,799
0.3942%
$4.99M
+2,866%
Faerm Michael E.
Sr VP & Chief Business Officer
279,422
0.3868%
$4.89M
+68.7%
WALTRIP WILLIAM H
Director
161,789
0.2239%
$2.83M
+14.0%
Haimovitz Jules
Director
152,692
0.2114%
$2.67M
+1,152%
DiPaolo Mark
Director
140,492
0.1945%
$2.46M
Schlesinger Sarah J.
Director
140,492
0.1945%
$2.46M
Odysseas Kostas D
Director
122,625
0.1697%
$2.15M
Basso Stephen
Chief Financial Officer
88,013
0.1218%
$1.54M
FRIEDMAN CATHY
Director
73,805
0.1022%
$1.29M
+36.8%
PEPE PAUL
Director
73,805
0.1022%
$1.29M
+36.8%
Tyree James L
Director
70,554
0.0977%
$1.24M
+39.2%
Birx Deborah
Director
58,984
0.0816%
$1.03M
+448.8%
LEPORE PATRICK G
Director
58,278
0.0807%
$1.02M
DUNCAN BARBARA GAYLE
Director
52,318
0.0724%
$916.49K
Small Derek A
Director
45,035
0.0623%
$788.91K
+386.9%
Srivastava Sapna
Director
44,096
0.0610%
$772.46K
+222.4%
Ronsheim Matthew
See Remarks
40,510
0.0561%
$709.64K
+33.2%
Linden Josephine
Director
15,194
0.0210%
$266.16K
Insider
Date
Role
Action
Shares
Price
Amount
DENNER ALEXANDER J
6 Mar 2025
10% owner
Sell indirect
1,196,746
$17.52
$20.96M
DENNER ALEXANDER J
5 Mar 2025
10% owner
Sell indirect
270,374
$17.63
$4.77M
DENNER ALEXANDER J
4 Mar 2025
10% owner
Sell indirect
151,175
$17.63
$2.67M
Zhen Marianne
15 Nov 2023
Chief Accounting Officer
Sell
5,405
$13.97
$75.51K
Zhen Marianne
15 Nov 2023
Chief Accounting Officer
Sell
5,589
$14.01
$78.30K
DENNER ALEXANDER J
15 Jun 2023
10% owner
Buy indirect
62,000
$13.13
$814.20K
DENNER ALEXANDER J
6 Jun 2023
10% owner
Buy indirect
8,000
$13.05
$104.38K
DENNER ALEXANDER J
5 Jun 2023
10% owner
Buy indirect
7,000
$13.04
$91.30K
DENNER ALEXANDER J
30 May 2023
10% owner
Buy indirect
120,000
$13.01
$1.56M
DENNER ALEXANDER J
26 May 2023
10% owner
Buy indirect
30,000
$13.12
$393.73K
DENNER ALEXANDER J
25 May 2023
10% owner
Buy indirect
50,000
$13.09
$654.33K
DENNER ALEXANDER J
18 May 2023
10% owner
Buy indirect
10,000
$13.05
$130.54K
DENNER ALEXANDER J
17 May 2023
10% owner
Buy indirect
50,000
$13.07
$653.69K
DENNER ALEXANDER J
11 May 2023
10% owner
Buy indirect
290,000
$12.34
$3.58M
Raifeld Pavel
10 Mar 2023
Chief Executive Officer
Buy
3,000
$10.87
$32.60K
Zhen Marianne
20 Aug 2021
Chief Accounting Officer
Sell
1,129
$15.89
$17.94K
Zhen Marianne
19 Aug 2021
Chief Accounting Officer
Sell
2,802
$16.02
$44.89K
Bickerstaff George
24 May 2021
Director
Buy
10,000
$13.46
$134.62K
Bickerstaff George
21 May 2021
Director
Buy
10,000
$12.97
$129.67K
GSK plc
20 May 2021
10% owner
Sell indirect
32,005,260
$12.25
$392.06M
Zhen Marianne
24 Feb 2020
Chief Accounting Officer
Sell
2,954
$14.78
$43.66K
Bickerstaff George
27 Feb 2019
Director
Buy
15,000
$15.90
$238.50K
Zhen Marianne
26 Feb 2019
Chief Accounting Officer
Sell
5,617
$16.00
$89.87K
Bickerstaff George
21 Feb 2019
Director
Buy
10,000
$14.90
$148.96K
HULME GEOFFREY
15 Feb 2019
Interim PEO
Buy
7,000
$14.80
$103.60K
Witek Theodore J. Jr.
21 Aug 2018
Sr. VP & Chief Scientific Off.
Sell
8,504
$14.12
$120.08K
ABERCROMBIE GEORGE B
21 Aug 2018
Sr. VP & Chief Comm. Officer
Sell
8,000
$14.11
$112.84K
ABERCROMBIE GEORGE B
21 May 2018
Sr. VP & Chief Comm. Officer
Sell
8,000
$14.40
$115.20K
dEsparbes Eric
21 May 2018
SVP and CFO
Sell
5,808
$14.40
$83.62K
ABERCROMBIE GEORGE B
21 Feb 2018
Sr. VP & Chief Comm. Officer
Sell
8,000
$16.51
$132.10K
Witek Theodore J. Jr.
21 Feb 2018
Sr. VP & Chief Scientific Off.
Sell
9,890
$16.60
$164.15K
dEsparbes Eric
21 Feb 2018
Interim PEO, SVP and CFO
Sell
5,378
$16.52
$88.83K
Aguiar Michael W
4 Dec 2017
President & Chief Exec Officer
Sell
12,022
$13.13
$157.79K
dEsparbes Eric
21 Nov 2017
SVP and CFO
Sell
13,460
$13.31
$179.17K
ABERCROMBIE GEORGE B
21 Nov 2017
Sr. VP & Chief Comm. Officer
Sell
5,215
$13.26
$69.15K
Witek Theodore J. Jr.
21 Nov 2017
Sr. VP & Chief Scientific Off.
Sell
13,000
$13.29
$172.79K
dEsparbes Eric
20 Nov 2017
SVP and CFO
Sell
1,825
$13.04
$23.80K
dEsparbes Eric
21 Aug 2017
SVP and CFO
Sell
1,825
$12.20
$22.27K
dEsparbes Eric
22 May 2017
SVP and CFO
Sell
1,825
$11.85
$21.63K
Witek Theodore J. Jr.
22 May 2017
Sr. VP & Chief Scientific Off.
Sell
7,815
$12.01
$93.86K
dEsparbes Eric
21 Feb 2017
SVP and CFO
Sell
1,825
$12.07
$22.03K
Witek Theodore J. Jr.
22 Nov 2016
Sr. VP & Chief Scientific Off.
Sell
3,700
$10.84
$40.12K
dEsparbes Eric
21 Nov 2016
SVP and CFO
Sell
1,800
$10.89
$19.60K

What was left out

Form 4 filings counted 190
Amendments (4/A) skipped 6
Filings about a different issuer 13
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 2,883,418
Sales filed before the plan box existed 23
History held since 27 Oct 2016